Hazra S - Search Results

1

Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma.

St John MA, Dohadwala M, Luo J, Wang G, Lee G, Shih H, Heinrich E, Krysan K, Walser T, Hazra S, Zhu L, Lai C, Abemayor E, Fishbein M, Elashoff DA, Sharma S, Dubinett SM. St John MA, et al. Among authors: hazra s. Clin Cancer Res. 2009 Oct 1;15(19):6018-27. doi: 10.1158/1078-0432.CCR-09-0011. Epub 2009 Sep 29. Clin Cancer Res. 2009. PMID: 19789323 Free PMC article.

2

Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer.

Cui X, Zhang L, Luo J, Rajasekaran A, Hazra S, Cacalano N, Dubinett SM. Cui X, et al. Among authors: hazra s. Oncogene. 2007 Jun 21;26(29):4253-60. doi: 10.1038/sj.onc.1210222. Epub 2007 Jan 22. Oncogene. 2007. PMID: 17237818

3

Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.

Mao JT, Cui X, Reckamp K, Liu M, Krysan K, Dalwadi H, Sharma S, Hazra S, Strieter R, Gardner B, Dubinett SM. Mao JT, et al. Among authors: hazra s. Clin Lung Cancer. 2005 Jul;7(1):30-9. doi: 10.3816/CLC.2005.n.019. Clin Lung Cancer. 2005. PMID: 16098242 Review.

4

Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.

Hazra S, Batra RK, Tai HH, Sharma S, Cui X, Dubinett SM. Hazra S, et al. Mol Pharmacol. 2007 Jun;71(6):1715-20. doi: 10.1124/mol.106.033357. Epub 2007 Apr 5. Mol Pharmacol. 2007. PMID: 17412838

5

Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.

Hazra S, Dubinett SM. Hazra S, et al. Prostaglandins Leukot Essent Fatty Acids. 2007 Jul;77(1):51-8. doi: 10.1016/j.plefa.2007.05.006. Epub 2007 Aug 13. Prostaglandins Leukot Essent Fatty Acids. 2007. PMID: 17697767 Free PMC article.

6

Inflammation and lung carcinogenesis: applying findings in prevention and treatment.

Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM. Peebles KA, et al. Among authors: hazra s. Expert Rev Anticancer Ther. 2007 Oct;7(10):1405-21. doi: 10.1586/14737140.7.10.1405. Expert Rev Anticancer Ther. 2007. PMID: 17944566 Review.

7

The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.

Hazra S, Peebles KA, Sharma S, Mao JT, Dubinett SM. Hazra S, et al. PPAR Res. 2008;2008:790568. doi: 10.1155/2008/790568. PPAR Res. 2008. PMID: 18769553 Free PMC article.

8

Focusing downstream in lung cancer prevention: 15-hydroxyprostaglandin dehydrogenase.

Dubinett SM, Mao JT, Hazra S. Dubinett SM, et al. Among authors: hazra s. Cancer Prev Res (Phila). 2008 Sep;1(4):223-5. doi: 10.1158/1940-6207.CAPR-08-0148. Cancer Prev Res (Phila). 2008. PMID: 19138963 No abstract available.

9

Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy.

Liclican EL, Walser TC, Hazra S, Krysan K, Park SJ, Pagano PC, Gardner BK, Larsen JE, Minna JD, Dubinett SM. Liclican EL, et al. Among authors: hazra s. Cancer Prev Res (Phila). 2014 Aug;7(8):845-55. doi: 10.1158/1940-6207.CAPR-14-0063. Epub 2014 Jun 9. Cancer Prev Res (Phila). 2014. PMID: 24913817 Free PMC article.

10

Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer.

Baratelli F, Takedatsu H, Hazra S, Peebles K, Luo J, Kurimoto PS, Zeng G, Batra RK, Sharma S, Dubinett SM, Lee JM. Baratelli F, et al. Among authors: hazra s. J Transl Med. 2008 Jul 22;6:38. doi: 10.1186/1479-5876-6-38. J Transl Med. 2008. PMID: 18644162 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

466 results

Search Page

Filters